announcements & circulars-凯发88

english 凯发88-凯发vip-娱乐凯发app下载中文繁体

english 凯发88-凯发vip-娱乐凯发app下载中文繁体

investors

information disclosure

listing documents

financial reports

announcements & circulars

company presentation

corporate governance

stock information

ir contacts

email subscription

announcements & circulars

the announcement begins in december 2019

voluntary announcement - kn046 was granted orphan drug designation by the u.s. fda 2020-09-03
interim results announcement for the six months ended june 30, 2020 2020-08-28
date of board meeting 2020-08-18
monthly return of equity issuer on movements in securities for the month ended 31 july 2020 2020-08-06
change of joint company secretary and process agent and waiver from strict compliance with rules 3.28 and 8.17 of the listing rules 2020-07-20
monthly return of equity issuer on movements in securities for the month ended 30 june 2020 2020-07-03
inside information announcement - completion of placing of existing shares by controlling shareholder 2020-06-16
inside information announcement - placing of existing shares by controlling shareholder 2020-06-12
voluntary announcement - co-development of antibody for coronavirus treatment with institut pasteur of shanghai 2020-06-10
voluntary announcement - strategic collaboration with sanofi on kn026 in her2 breast cancer 2020-06-09